Tech Company Financing Transactions

Solstice Neurosciences Funding Round

Solstice Neurosciences closed a $6 million funding round on 3/31/2005. Investors included Investor Growth Capital, Morgan Stanley Expansion Capital and Oxford Bioscience Partners.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

701 Gateway Boulevard 250
South San Francisco, CA 94080
USA

Phone

(650) 243-4400

Website

www.solsticeneuro.com

Email Address

[email protected]

Overview

Solstice Neurosciences, Inc. is a biopharmaceuticalcompany focused on the development, manufacturing, sales and marketing ofspecialty products.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Dennis Smith

        

Chief Financial Officer

Michael Pagnotta

        

VP - Operations

Patrick Murphy

        

Browse more venture capital transactions:

Prev: 3/31/2005: LiteScape Technologies venture capital transaction
Next: 3/31/2005: WhittmanHart venture capital transaction

Share this article

Where The Data Comes From

We report on funding rounds that are announced publicly. All VC database entries reported here are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary